Coherus BioSciences Inc (CHRS)
0.7108
+0.04
(+6.09%)
USD |
NASDAQ |
Nov 05, 10:27
Coherus BioSciences Total Liabilities (Quarterly): 758.96M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 758.96M |
| March 31, 2024 | 845.39M |
| December 31, 2023 | 823.03M |
| September 30, 2023 | 717.38M |
| June 30, 2023 | 644.36M |
| March 31, 2023 | 598.93M |
| December 31, 2022 | 618.26M |
| September 30, 2022 | 648.04M |
| June 30, 2022 | 568.63M |
| March 31, 2022 | 580.82M |
| December 31, 2021 | 581.61M |
| September 30, 2021 | 610.97M |
| June 30, 2021 | 583.32M |
| March 31, 2021 | 565.63M |
| December 31, 2020 | 560.68M |
| September 30, 2020 | 548.00M |
| June 30, 2020 | 543.23M |
| March 31, 2020 | 309.26M |
| December 31, 2019 | 303.71M |
| September 30, 2019 | 271.36M |
| June 30, 2019 | 244.44M |
| Date | Value |
|---|---|
| March 31, 2019 | 224.63M |
| December 31, 2018 | 138.06M |
| September 30, 2018 | 129.07M |
| June 30, 2018 | 126.48M |
| March 31, 2018 | 131.55M |
| December 31, 2017 | 132.08M |
| September 30, 2017 | 134.85M |
| June 30, 2017 | 141.39M |
| March 31, 2017 | 150.54M |
| December 31, 2016 | 159.13M |
| September 30, 2016 | 160.64M |
| June 30, 2016 | 313.05M |
| March 31, 2016 | 293.11M |
| December 31, 2015 | 219.31M |
| September 30, 2015 | 162.27M |
| June 30, 2015 | 153.18M |
| March 31, 2015 | 115.16M |
| December 31, 2014 | 120.46M |
| September 30, 2014 | 120.00M |
| June 30, 2014 | 107.61M |
| December 31, 2013 | 89.83M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
303.71M
Minimum
Dec 2019
845.39M
Maximum
Mar 2024
600.54M
Average
583.32M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Repligen Corp | 875.56M |
| Evoke Pharma Inc | 9.471M |
| Personalis Inc | 73.23M |
| Maravai LifeSciences Holdings Inc | 671.19M |
| Tempus AI Inc | 766.36M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 674.86M |
| Shareholders Equity (Quarterly) | -84.11M |
| Debt to Equity Ratio | -3.14 |
| Current Ratio | 1.205 |
| Net Debt Paydown Yield | 20.83% |